| Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double … JS Heier, AM Khanani, CQ Ruiz, K Basu, PJ Ferrone, C Brittain, ... The Lancet 399 (10326), 729-740, 2022 | 267 | 2022 |
| Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo … A Lotery, S Sivaprasad, A O'Connell, RA Harris, L Culliford, L Ellis, A Cree, ... The Lancet 395 (10220), 294-303, 2020 | 169 | 2020 |
| A longitudinal study of Stargardt disease: quantitative assessment of fundus autofluorescence, progression, and genotype correlations K Fujinami, N Lois, R Mukherjee, VA McBain, K Tsunoda, K Tsubota, ... Investigative ophthalmology & visual science 54 (13), 8181-8190, 2013 | 155 | 2013 |
| Managing antiplatelet and anticoagulant drugs in patients undergoing elective ophthalmic surgery CA Kiire, R Mukherjee, N Ruparelia, D Keeling, B Prendergast, JH Norris British Journal of Ophthalmology 98 (10), 1320-1324, 2014 | 61 | 2014 |
| Unilateral retinitis pigmentosa occurring in an individual with a germline mutation in the RP1 gene R Mukhopadhyay, GE Holder, AT Moore, AR Webster Archives of Ophthalmology 129 (7), 954-956, 2011 | 58 | 2011 |
| Autosomal dominant retinitis pigmentosa with intrafamilial variability and incomplete penetrance in two families carrying mutations in PRPF8 CG Maubaret, V Vaclavik, R Mukhopadhyay, NH Waseem, A Churchill, ... Investigative ophthalmology & visual science 52 (13), 9304-9309, 2011 | 50 | 2011 |
| The clinical features of retinal disease due to a dominant mutation in RPE65 S Hull, R Mukherjee, GE Holder, AT Moore, AR Webster Molecular vision 22, 626, 2016 | 48 | 2016 |
| Prognosis for splicing factor PRPF8 retinitis pigmentosa, novel mutations and correlation between human and yeast phenotypes KV Towns, A Kipioti, V Long, M McKibbin, C Maubaret, V Vaclavik, ... Human mutation 31 (5), E1361-E1376, 2010 | 44 | 2010 |
| A detailed phenotypic assessment of individuals affected by MFRP-related oculopathy R Mukhopadhyay, PI Sergouniotis, DS Mackay, AC Day, G Wright, ... Molecular vision 16, 540, 2010 | 42 | 2010 |
| United Kingdom Diabetic Retinopathy Electronic Medical Record (UK DR EMR) Users Group: report 4, real-world data on the impact of deprivation on the presentation of diabetic … AK Denniston, AY Lee, CS Lee, DP Crabb, C Bailey, PL Lip, P Taylor, ... British Journal of Ophthalmology 103 (6), 837-843, 2019 | 35 | 2019 |
| Preserved visual function in retinal dystrophy due to hypomorphic RPE65 mutations S Hull, GE Holder, AG Robson, R Mukherjee, M Michaelides, AR Webster, ... British Journal of Ophthalmology 100 (11), 1499-1505, 2016 | 28 | 2016 |
| A detailed phenotypic description of autosomal dominant cone dystrophy due to a de novo mutation in the GUCY2D gene R Mukherjee, AG Robson, GE Holder, A Stockman, CA Egan, AT Moore, ... Eye 28 (4), 481-487, 2014 | 25 | 2014 |
| A 112 kb deletion in chromosome 19q13. 42 leads to retinitis pigmentosa AM Rose, R Mukhopadhyay, AR Webster, SS Bhattacharya, NH Waseem Investigative Ophthalmology & Visual Science 52 (9), 6597-6603, 2011 | 25 | 2011 |
| Multicentre study of 4626 patients assesses the effectiveness, safety and burden of two categories of treatments for central retinal vein occlusion: intravitreal anti-vascular … R Gale, C Gill, M Pikoula, AY Lee, RLW Hanson, S Denaxas, C Egan, ... British Journal of Ophthalmology 105 (11), 1571-1576, 2021 | 22 | 2021 |
| Real world evidence on 5661 patients treated for macular oedema secondary to branch retinal vein occlusion with intravitreal anti-vascular endothelial growth factor … R Gale, M Pikoula, AY Lee, S Denaxas, C Egan, A Tufail, P Taylor British Journal of Ophthalmology 105 (4), 549-554, 2021 | 20 | 2021 |
| Estimating excess visual loss in people with neovascular age-related macular degeneration during the COVID-19 pandemic DS Thomas, AN Warwick, A Olvera-Barrios, C Egan, R Schwartz, S Patra, ... MedRxiv, 2020.06. 02.20120642, 2020 | 17 | 2020 |
| A rare complication from prostaglandin analogue therapy R Mukhopadhyay, A Plumb Clinical and Experimental Optometry 92 (2), 137-138, 2009 | 17 | 2009 |
| Treatment choices for diabetic macular oedema: a guideline for when to consider an intravitreal corticosteroid, including adaptations for the COVID-19 era L Downey, N Acharya, H Devonport, R Gale, M Habib, V Manjunath, ... BMJ Open Ophthalmology 6 (1), e000696, 2021 | 16 | 2021 |
| Evolving treatment patterns and outcomes of neovascular age-related macular degeneration over a decade R Schwartz, A Warwick, A Olvera-Barrios, M Pikoula, AY Lee, S Denaxas, ... Ophthalmology Retina 5 (8), e11-e22, 2021 | 10 | 2021 |
| The natural history of Leber congenital Amaurosis and cone–rod dystrophy associated with variants in the GUCY2D Gene LC Hahn, M Georgiou, H Almushattat, MJ van Schooneveld, ... Ophthalmology Retina 6 (8), 711-722, 2022 | 9 | 2022 |
